Our facility is equipped with the OCT SPECTRALIS NEW spectral imaging device, which currently ranks among the most advanced in its field.
Through early diagnosis using the OCT SPECTRALIS NEW, we are able to detect pathological changes in the retina and optic nerve several years earlier than would be possible with a conventional slit-lamp examination or perimetry. Early diagnosis enables significantly more effective treatment of eye conditions.
Using a laser beam, the device creates a three-dimensional image, making it possible to diagnose early-stage age-related macular degeneration (AMD) and glaucoma within a matter of minutes — the two most common eye conditions leading to loss of visual function.
Glaucoma is a condition characterised by the irreversible degeneration of optic nerve fibres and retinal ganglion cells.
Macular degeneration (AMD) is a condition in which destructive and irreversible remodelling of the retina occurs. Serious retinal damage can be prevented through comprehensive treatment with anti-VEGF agents, laser retinal treatment, photodynamic therapy, or, where appropriate, microsurgical intervention.
Advantages of Diagnostics with the OCT SPECTRALIS NEW
- the examination is fast and painless, performed without contact with the eye
- the device is capable of compensating for eye movements
- in most cases, the examination does not require pupil dilation with mydriatics
- 3D visualisation of results
- diagnosis of macular degeneration, glaucoma, and diabetic retinopathy
- early examination minimises delays in treatment and loss of visual function
The price of examination with the OCT SPECTRALIS NEW is governed by the current price list.